{"id":"https://openalex.org/W1986274661","doi":"https://doi.org/10.1097/00001756-199604100-00019","title":"The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle","display_name":"The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle","alternate_titles":[],"publication_year":1996,"publication_date":"1996-04-01","ids":{"openalex":"https://openalex.org/W1986274661","doi":"https://doi.org/10.1097/00001756-199604100-00019","mag":"1986274661","pmid":"https://pubmed.ncbi.nlm.nih.gov/8804049"},"language":"en","primary_location":{"id":"doi:10.1097/00001756-199604100-00019","doi":"https://doi.org/10.1097/00001756-199604100-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001756-199604100-00019","pdf_url":null,"source":{"id":"https://openalex.org/S121278948","display_name":"Neuroreport","issn_l":"0959-4965","issn":["0959-4965","1473-558X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NeuroReport","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1986274661"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109917559","display_name":"Kurt Rasmussen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kurt Rasmussen","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076545823","display_name":"Janet F. Czachura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Janet F. Czachura","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110071815","display_name":"Mary Jeanne Kallman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary Jeanne Kallman","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068627088","display_name":"David R. Helton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David R. Helton","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":4.2891,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.93564985,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":92},"biblio":{"volume":"7","issue":"5","first_page":"1050","last_page":"1052"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.8101000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.8101000189781189,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.15160000324249268,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotine-withdrawal","display_name":"nicotine withdrawal","score":0.8809999823570251},{"id":"https://openalex.org/keywords/acoustic-startle-response","display_name":"acoustic startle response","score":0.7680000066757202},{"id":"https://openalex.org/keywords/cck-b-receptor-antagonist","display_name":"CCK-B receptor antagonist","score":0.7839999794960022},{"id":"https://openalex.org/keywords/cholecystokinin","display_name":"cholecystokinin","score":0.765999972820282},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.6740000247955322},{"id":"https://openalex.org/keywords/nicotine-dependence","display_name":"nicotine dependence","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7716422080993652},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.6650223135948181},{"id":"https://openalex.org/C137431309","wikidata":"https://www.wikidata.org/wiki/Q1383576","display_name":"Moro reflex","level":3,"score":0.5228784084320068},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.48157787322998047},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.4605696499347687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4179666340351105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25805729627609253},{"id":"https://openalex.org/C83974742","wikidata":"https://www.wikidata.org/wiki/Q179405","display_name":"Reflex","level":2,"score":0.23954609036445618},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09048327803611755}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006727","descriptor_name":"Hormone Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011949","descriptor_name":"Receptors, Cholecystokinin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001756-199604100-00019","doi":"https://doi.org/10.1097/00001756-199604100-00019","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001756-199604100-00019","pdf_url":null,"source":{"id":"https://openalex.org/S121278948","display_name":"Neuroreport","issn_l":"0959-4965","issn":["0959-4965","1473-558X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NeuroReport","raw_type":"journal-article"},{"id":"pmid:8804049","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8804049","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuroreport","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2022311112","https://openalex.org/W2028747846","https://openalex.org/W2070055547","https://openalex.org/W3176246039","https://openalex.org/W2092929554","https://openalex.org/W2020230164","https://openalex.org/W2002199969","https://openalex.org/W3087417191","https://openalex.org/W152104336","https://openalex.org/W2288993770"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,37,61],"explore":[3],"the":[4,12,18,29,53,58,72,89,94],"potential":[5],"clinical":[6],"utility":[7],"of":[8,14,32],"CCK-B":[9,73,102],"antagonists":[10,103],"for":[11,40,66,109,122],"treatment":[13,70,108],"nicotine":[15,38,90,111],"withdrawal":[16,27,65,112],"symptoms,":[17],"auditory":[19],"startle":[20,83,96],"reflex":[21],"was":[22],"examined":[23],"in":[24,85,93,114],"rats":[25],"undergoing":[26],"from":[28],"chronic":[30],"administration":[31],"nicotine.":[33],"Rats":[34],"were":[35,55],"exposed":[36],"continuously":[39],"12":[41,51],"days":[42,52],"(6":[43],"mg":[44],"kg-1":[45],"day-1)":[46],"via":[47],"osmotic":[48],"minipumps.":[49],"After":[50],"pumps":[54],"removed":[56],"and":[57,116],"animals":[59],"allowed":[60],"go":[62],"through":[63],"spontaneous":[64],"several":[67],"days.":[68],"Acute":[69],"with":[71],"antagonist":[74],"LY288513,":[75],"at":[76],"doses":[77],"that":[78,101],"have":[79],"no":[80],"effect":[81],"on":[82],"responses":[84],"naive":[86],"rats,":[87],"blocked":[88],"withdrawal-induced":[91],"increase":[92],"acoustic":[95],"reflex.":[97],"These":[98],"results":[99],"indicate":[100],"may":[104,117],"be":[105],"an":[106],"efficacious":[107],"some":[110],"symptoms":[113],"man":[115],"represent":[118],"a":[119],"novel":[120],"pharmacotherapy":[121],"smoking":[123],"cessation.":[124]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1986274661","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
